20 Jul Draconis Pharma participate in the consorcium Acinetoclicinic
Draconis Pharma participate in the consorcium Acinetoclicinic, to develop a novel vaccine against antibiotic-resistant bacterium, acitenobacter baumannii. This research is leaded by Spanish Company Vaxdyn and supported by the 2016 RETOS-COLABORACIÓN, program of the Ministry of Economy, Industry and competitiveness of Spain.